Apex used 8 minutes per zone, 3× weekly for 12 weeks. No topicals or systemics.
Six peer-reviewed studies supporting cold atmospheric plasma. Click to read.
Apex used 8 minutes per zone, 3× weekly for 12 weeks. No topicals or systemics.
Apex used 10 minutes per zone, 3× weekly for 8 weeks. Continued previous moisturiser only.
Apex used 7 minutes per zone, 3× weekly for 12 weeks. Topicals paused for the trial.
Apex used 8 minutes per zone, 4× weekly for 12 weeks. Patient was prior IPL/laser-fatigued.
Individual results vary. Cold atmospheric plasma is FDA cleared (510k). Clinical-use protocols shown are practitioner-administered; consult your physician for individual indications.
We introduced Apex initially for inflammatory acne and post-procedure recovery patients. Within a few weeks it became one of the most requested treatments in clinic. The skin stays noticeably calmer afterward compared to many heat-based modalities. Very impressive tolerability profile.
Apex filled a gap we honestly struggled with for years — patients who needed correction but could no longer tolerate aggressive treatments. Redness settles faster, irritation is lower, and clients consistently comment that their skin feels more stable after sessions.
We’ve trialled a large number of device technologies over the years and most never become part of long-term protocols. Apex did. Especially for chronic inflammatory patients who are exhausted from prescription cycling and over-treatment.
What stood out clinically was consistency. Less inflammation, calmer recovery, better skin tolerance overall. We started with a few sessions experimentally and now use Apex across a significant portion of our acne-focused protocols.
Patients increasingly want results without trauma. That’s where Apex makes sense. It gives us a non-thermal option that still feels clinically serious. Especially useful for reactive skin types where lasers and aggressive resurfacing can become risky.
Honestly one of the more interesting technologies I’ve worked with recently. Patients who normally stay inflamed for days after treatments are recovering much more comfortably. The feedback from long-term acne and rosacea clients has been especially strong.
I had an entire shelf of products and my skin was still unpredictable. Apex is probably the first thing that actually reduced how much I rely on skincare. My skin just feels more controlled now.
I bought it because the mechanism made sense to me. What surprised me was how noticeable the difference became over time. Less redness, fewer flare-ups, smoother texture. My skin finally stopped feeling constantly irritated.
I still get hormonal breakouts, but they’re nowhere near as aggressive now. They calm down faster and don’t linger the same way. Easily the most effective device I’ve personally used.
After years of peels and lasers I became extremely cautious with treatments. Apex felt different immediately because there was no heat or trauma involved. My skin looks healthier overall without going through harsh recovery cycles anymore.
What sold me was that it felt more like a controlled technology than beauty marketing. After about a month my skin looked calmer and more even than it has in years. I’ve simplified my entire routine because of it.
Most devices trigger irritation for me within minutes. Apex didn’t. That alone impressed me. Over time the persistent redness around my cheeks softened noticeably and my skin became far less reactive day to day.
Apex delivers higher cold atmospheric plasma output and includes interchangeable treatment attachments for different anatomical areas and protocol depths. Nova is fixed-output and single-attachment, optimised for daily home use on facial skin. Both use the same plasma primitive; Apex gives the clinician (or advanced user) control of dose, duration and head.
Inflammatory dermatoses (acne, rosacea), post-procedure healing, atopic and barrier-dysfunction cases, microbiome-driven concerns, peri-procedural recovery alongside IPL, laser or RF. Apex is the device when protocol depth matters more than ease-of-use.
Yes. Cold atmospheric plasma is chromophore-independent — unlike IPL and most lasers, it doesn’t interact with melanin, so it carries no Fitzpatrick-type pigmentation risk. Safe across the full I–VI range.
Default protocol is 5–10 minutes per treatment zone, 2–3x weekly, scaled to the patient’s tolerance and condition. Full protocol guidance ships with the device. Treatment cadence and dose are adjusted per case rather than fixed; that’s why the controls are exposed.
Cold atmospheric plasma operates on a different mechanism — reactive oxygen/nitrogen species delivery, not light or heat. Common stack: IPL or laser session, then Apex on the treated area to accelerate barrier recovery and reduce post-procedural inflammation. Patients tolerate the combination well and clinic outcomes are typically faster.
Each device ships with a clinical protocol guide, indication-by-indication treatment matrix, and onboarding documentation. No formal certification required for ownership. We assume buyers have working knowledge of energy-based dermatology devices; if you don’t, Nova is the better starting point.
Yes. Apex is rated for full-body use — décolletage, hands, scalp, body acne zones. The interchangeable attachments are sized for different anatomical regions; the protocol guide includes body-area variants.
We work with verified clinical accounts on Nova wholesale terms for patient retail. The continuity model — Apex in clinic, Nova at home — is the standard recommendation. Reach out via the inquiry form for clinical account setup.
Full documentation pack: 6 peer-reviewed studies, mechanism explainer, indication matrix, before/after photography library, consent-form templates. Available to verified clinical accounts.
Apex is a clinical-grade device with the manufacturing tolerances and quality control that implies — not a beauty tool. Build cost reflects the medical-grade plasma generation unit, the interchangeable-attachment system, and the durability requirements for daily clinical use. Lifetime warranty included. Single capital cost, no consumables, no subscription. Reference comparable clinic-tier plasma devices at £3,000+.
Clinical-grade cold atmospheric plasma.